These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 37315875)

  • 1. Plant glycoengineering for designing next-generation vaccines and therapeutic proteins.
    Strasser R
    Biotechnol Adv; 2023 Oct; 67():108197. PubMed ID: 37315875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Production of therapeutic glycoproteins in glycoengineered plant: old farm for new crops.
    Kao MR; Karmarkar Saldivar R; Hsieh YSY
    Curr Opin Biotechnol; 2024 Jun; 87():103145. PubMed ID: 38781701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Roadmap for the Molecular Farming of Viral Glycoprotein Vaccines: Engineering Glycosylation and Glycosylation-Directed Folding.
    Margolin E; Crispin M; Meyers A; Chapman R; Rybicki EP
    Front Plant Sci; 2020; 11():609207. PubMed ID: 33343609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycosylation control technologies for recombinant therapeutic proteins.
    Gupta SK; Shukla P
    Appl Microbiol Biotechnol; 2018 Dec; 102(24):10457-10468. PubMed ID: 30334089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-glycosylation modification of plant-derived virus-like particles: an application in vaccines.
    Kim HS; Jeon JH; Lee KJ; Ko K
    Biomed Res Int; 2014; 2014():249519. PubMed ID: 24971324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Main Strategies of Plant Expression System Glycoengineering for Producing Humanized Recombinant Pharmaceutical Proteins.
    Rozov SM; Permyakova NV; Deineko EV
    Biochemistry (Mosc); 2018 Mar; 83(3):215-232. PubMed ID: 29625542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bacterial glycoengineering: Cell-based and cell-free routes for producing biopharmaceuticals with customized glycosylation.
    Palma JA; Bunyatov MI; Hulbert SW; Jewett MC; DeLisa MP
    Curr Opin Chem Biol; 2024 Aug; 81():102500. PubMed ID: 38991462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Controlled glycosylation of plant-produced recombinant proteins.
    Strasser R; Altmann F; Steinkellner H
    Curr Opin Biotechnol; 2014 Dec; 30():95-100. PubMed ID: 25000187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycoengineering of CHO Cells to Improve Product Quality.
    Wang Q; Yin B; Chung CY; Betenbaugh MJ
    Methods Mol Biol; 2017; 1603():25-44. PubMed ID: 28493121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-glycosylation of recombinant pharmaceutical glycoproteins produced in transgenic plants: towards an humanisation of plant N-glycans.
    Lerouge P; Bardor M; Pagny S; Gomord V; Faye L
    Curr Pharm Biotechnol; 2000 Dec; 1(4):347-54. PubMed ID: 11467331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging technologies for making glycan-defined glycoproteins.
    Wang LX; Lomino JV
    ACS Chem Biol; 2012 Jan; 7(1):110-22. PubMed ID: 22141574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using glyco-engineering to produce therapeutic proteins.
    Dicker M; Strasser R
    Expert Opin Biol Ther; 2015; 15(10):1501-16. PubMed ID: 26175280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-glycosylation, a leading role in viral infection and immunity development.
    Pandey VK; Sharma R; Prajapati GK; Mohanta TK; Mishra AK
    Mol Biol Rep; 2022 Aug; 49(8):8109-8120. PubMed ID: 35364718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of glycosylation on viral vaccines.
    Lembo A; Molinaro A; De Castro C; Berti F; Biagini M
    Carbohydr Polym; 2024 Oct; 342():122402. PubMed ID: 39048237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Producing Biologics with Defined N-Glycosylation in Plants.
    Esqueda A; Chen Q
    Methods Mol Biol; 2023; 2597():235-250. PubMed ID: 36374425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-glycosylation engineering of plants for the biosynthesis of glycoproteins with bisected and branched complex N-glycans.
    Castilho A; Gattinger P; Grass J; Jez J; Pabst M; Altmann F; Gorfer M; Strasser R; Steinkellner H
    Glycobiology; 2011 Jun; 21(6):813-23. PubMed ID: 21317243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant plant-derived human IgE glycoproteomics.
    Montero-Morales L; Maresch D; Castilho A; Turupcu A; Ilieva KM; Crescioli S; Karagiannis SN; Lupinek C; Oostenbrink C; Altmann F; Steinkellner H
    J Proteomics; 2017 May; 161():81-87. PubMed ID: 28400175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bacterial glycobiotechnology: A biosynthetic route for the production of biopharmaceutical glycans.
    Paliya BS; Sharma VK; Tuohy MG; Singh HB; Koffas M; Benhida R; Tiwari BK; Kalaskar DM; Singh BN; Gupta VK
    Biotechnol Adv; 2023 Oct; 67():108180. PubMed ID: 37236328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-glycosylation engineering of biopharmaceutical expression systems.
    Jacobs PP; Callewaert N
    Curr Mol Med; 2009 Sep; 9(7):774-800. PubMed ID: 19860659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell-based glycoengineering of extracellular vesicles through precise genome editing.
    Tian W; Zagami C; Chen J; Blomberg AL; Guiu LS; Skovbakke SL; Goletz S
    N Biotechnol; 2024 Nov; 83():101-109. PubMed ID: 39079597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.